Cargando…

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

BACKGROUND: Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine can...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Ming Shum, Leung, Nancy Hiu Lan, Cheung, Chung Yan, Li, Ping Hung, Lee, Horace Hok Yeung, Daëron, Marc, Peiris, Joseph Sriyal Malik, Bruzzone, Roberto, Jaume, Martial
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018502/
https://www.ncbi.nlm.nih.gov/pubmed/24885320
http://dx.doi.org/10.1186/1743-422X-11-82
_version_ 1782480078966358016
author Yip, Ming Shum
Leung, Nancy Hiu Lan
Cheung, Chung Yan
Li, Ping Hung
Lee, Horace Hok Yeung
Daëron, Marc
Peiris, Joseph Sriyal Malik
Bruzzone, Roberto
Jaume, Martial
author_facet Yip, Ming Shum
Leung, Nancy Hiu Lan
Cheung, Chung Yan
Li, Ping Hung
Lee, Horace Hok Yeung
Daëron, Marc
Peiris, Joseph Sriyal Malik
Bruzzone, Roberto
Jaume, Martial
author_sort Yip, Ming Shum
collection PubMed
description BACKGROUND: Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages. METHODS: We have used primary human immune cells to evaluate their susceptibility to infection by SARS-CoV in the presence of anti-Spike antibodies. Fluorescence microscopy and real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) were utilized to assess occurrence and consequences of infection. To gain insight into the underlying molecular mechanism, we performed mutational analysis with a series of truncated and chimeric constructs of fragment crystallizable γ receptors (FcγR), which bind antibody-coated pathogens. RESULTS: We show here that anti-Spike immune serum increased infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike-pseudotyped lentiviral particles (SARS-CoVpp). Macrophages infected with SARS-CoV, however, did not support productive replication of the virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance infection. Antibody-mediated infection was dependent on signaling-competent members of the human FcγRII family, which were shown to confer susceptibility to otherwise naïve ST486 cells, as binding of immune complexes to cell surface FcγRII was necessary but not sufficient to trigger antibody-dependent enhancement (ADE) of infection. Furthermore, only FcγRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp infection, thus providing additional information on the role of downstream signaling by FcγRII. CONCLUSIONS: These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors.
format Online
Article
Text
id pubmed-4018502
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40185022014-05-14 Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus Yip, Ming Shum Leung, Nancy Hiu Lan Cheung, Chung Yan Li, Ping Hung Lee, Horace Hok Yeung Daëron, Marc Peiris, Joseph Sriyal Malik Bruzzone, Roberto Jaume, Martial Virol J Research BACKGROUND: Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages. METHODS: We have used primary human immune cells to evaluate their susceptibility to infection by SARS-CoV in the presence of anti-Spike antibodies. Fluorescence microscopy and real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) were utilized to assess occurrence and consequences of infection. To gain insight into the underlying molecular mechanism, we performed mutational analysis with a series of truncated and chimeric constructs of fragment crystallizable γ receptors (FcγR), which bind antibody-coated pathogens. RESULTS: We show here that anti-Spike immune serum increased infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike-pseudotyped lentiviral particles (SARS-CoVpp). Macrophages infected with SARS-CoV, however, did not support productive replication of the virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance infection. Antibody-mediated infection was dependent on signaling-competent members of the human FcγRII family, which were shown to confer susceptibility to otherwise naïve ST486 cells, as binding of immune complexes to cell surface FcγRII was necessary but not sufficient to trigger antibody-dependent enhancement (ADE) of infection. Furthermore, only FcγRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp infection, thus providing additional information on the role of downstream signaling by FcγRII. CONCLUSIONS: These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors. BioMed Central 2014-05-06 /pmc/articles/PMC4018502/ /pubmed/24885320 http://dx.doi.org/10.1186/1743-422X-11-82 Text en Copyright © 2014 Yip et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yip, Ming Shum
Leung, Nancy Hiu Lan
Cheung, Chung Yan
Li, Ping Hung
Lee, Horace Hok Yeung
Daëron, Marc
Peiris, Joseph Sriyal Malik
Bruzzone, Roberto
Jaume, Martial
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
title Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
title_full Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
title_fullStr Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
title_full_unstemmed Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
title_short Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
title_sort antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018502/
https://www.ncbi.nlm.nih.gov/pubmed/24885320
http://dx.doi.org/10.1186/1743-422X-11-82
work_keys_str_mv AT yipmingshum antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT leungnancyhiulan antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT cheungchungyan antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT lipinghung antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT leehoracehokyeung antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT daeronmarc antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT peirisjosephsriyalmalik antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT bruzzoneroberto antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus
AT jaumemartial antibodydependentinfectionofhumanmacrophagesbysevereacuterespiratorysyndromecoronavirus